ES8301631A1 - Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar. - Google Patents

Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar.

Info

Publication number
ES8301631A1
ES8301631A1 ES500185A ES500185A ES8301631A1 ES 8301631 A1 ES8301631 A1 ES 8301631A1 ES 500185 A ES500185 A ES 500185A ES 500185 A ES500185 A ES 500185A ES 8301631 A1 ES8301631 A1 ES 8301631A1
Authority
ES
Spain
Prior art keywords
glycosidic
drug form
adjuvant
orally administered
administered drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES500185A
Other languages
English (en)
Other versions
ES500185A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interx Research Corp
Original Assignee
Interx Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interx Research Corp filed Critical Interx Research Corp
Publication of ES500185A0 publication Critical patent/ES500185A0/es
Publication of ES8301631A1 publication Critical patent/ES8301631A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

PREPARACION DE UN ANTIBIOTICO GLICOSIDICO O SIMILAR. SE PROPORCIONAN UN METODO Y UNA FORMA FARMACEUTICA PARA AUMENTAR LA ABSORCION ORAL DE LOS ANTIBIOTICOS GLICOSIDICOS Y AFINES TALES COMO LOS ANTIBIOTICOS DE MACROLIDA, AMINO-GLICOSIDOS, LINCOMICINA Y ANTRACICLINA Y ESPECIES QUIMICAS SIMILARES, POR ADMINISTRACION ORAL DE DICHOS ANTIBIOTICOS GLICOSIDICOS Y AFINES EN UN EXCIPIENTE ADECUADO FARMACEUTICAMENTE ACEPTABLE, AL QUE SE HA AGREGADO UN HIDROXIARILACIDO O HIDROXIARALQUILACIDO O UNA SAL, AMIDA O ESTER DE LOS MISMOS. EL HIDROXIARILACIDO, HIDROXIARALQUILACIDO O SAL, AMIDA O ESTER DE LOS MISMOS SE ENCUENTRA EN LA FORMA FARMACEUTICA EN CANTIDADES SUFICIENTES PARA SER EFECTIVO PARA AUMENTAR LA VELOCIDAD DE ABSORCION ORAL DEL ANTIBIOTICO GLICOSIDICO Y AFINES.
ES500185A 1980-03-07 1981-03-06 Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar. Expired ES8301631A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12810080A 1980-03-07 1980-03-07

Publications (2)

Publication Number Publication Date
ES500185A0 ES500185A0 (es) 1983-01-01
ES8301631A1 true ES8301631A1 (es) 1983-01-01

Family

ID=22433639

Family Applications (1)

Application Number Title Priority Date Filing Date
ES500185A Expired ES8301631A1 (es) 1980-03-07 1981-03-06 Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar.

Country Status (13)

Country Link
EP (1) EP0035770B1 (es)
JP (1) JPS579725A (es)
AT (1) ATE24398T1 (es)
AU (1) AU545885B2 (es)
CA (1) CA1166962A (es)
DE (1) DE3175733D1 (es)
DK (1) DK102081A (es)
ES (1) ES8301631A1 (es)
GR (1) GR74443B (es)
IE (1) IE52397B1 (es)
NZ (1) NZ196348A (es)
PT (1) PT72592B (es)
ZA (1) ZA811514B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU541247B2 (en) * 1979-12-20 1985-01-03 R.P. Scherer Corporation Adjuvants for rectal delivery of drug substances
IT1189285B (it) * 1982-05-28 1988-02-04 Nuovo Consor Sanitar Nazionale Sali dell'antibiotico eritromicina e del suo estere propionico con acidi ad attivita' terapeutica coadiuvante
FR2557453B1 (fr) * 1983-12-29 1988-02-19 Virbac Ctre Rech Biolog Nouvelle propriete pharmacocinetique des aminoglucosides
PA8444901A1 (es) * 1997-01-28 2000-05-24 Hoffmann La Roche Derivados de 5-aroilnaftaleno como agentes anti-inflamatorios
DE102004017141A1 (de) * 2004-04-01 2005-12-01 Bergische Universität Wuppertal Neue Gene aus Biosynthese Genclustern zur Synthese von Aminoglycosid-Antibiotika sowie damit herstellbare neue Aminoglycosid-Antibiotika
RU2016109404A (ru) * 2009-06-03 2018-11-26 АльгиФарма АС Обработка акинетобактерий альгинатными олигомерами и антибиотиками
ES2774962T3 (es) * 2013-03-05 2020-07-23 Enteris Biopharma Inc Productos farmacéuticos de administración oral

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3777018A (en) * 1967-03-31 1973-12-04 Schmid Inc Julius Compositions containing polyenic macro-lide and aryl derivative of aliphatic acid and method for treating hyper-lipidaemia
GB1559840A (en) * 1975-12-01 1980-01-30 Gist Brocades Nv Antifungal compositions
FR2379285A2 (fr) * 1977-02-08 1978-09-01 Expl Marques Brevets Et Nouvelle composition a base d'acide salicylique et de corticoide
US4268503A (en) * 1978-09-14 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. Antibacterial composition

Also Published As

Publication number Publication date
PT72592A (en) 1981-03-01
IE810453L (en) 1981-09-07
DE3175733D1 (en) 1987-02-05
NZ196348A (en) 1984-08-24
AU6805681A (en) 1981-09-10
GR74443B (es) 1984-06-28
ATE24398T1 (de) 1987-01-15
PT72592B (en) 1985-11-25
ES500185A0 (es) 1983-01-01
AU545885B2 (en) 1985-08-08
ZA811514B (en) 1982-10-27
IE52397B1 (en) 1987-10-14
CA1166962A (en) 1984-05-08
EP0035770A3 (en) 1981-09-23
DK102081A (da) 1981-09-08
EP0035770A2 (en) 1981-09-16
EP0035770B1 (en) 1986-12-30
JPS579725A (en) 1982-01-19

Similar Documents

Publication Publication Date Title
ES8301632A1 (es) Un metodo, para la preparacion de una formulacion farmaceutica de un agente bioactivo polar.
ES2117642T3 (es) Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
EP0305117A3 (en) 2',3'-dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections
NO179995C (no) Fremgangsmåte for fremstilling av legemiddel-lipidsystemer med lav toksisitet inneholdende polyen-antibiotika
ES8301631A1 (es) Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar.
GB1506664A (en) Antiviral compositions
IE40957L (en) 4- o-ó,d-glucopyranosyl -6-o-ó,d- xylohexopyranosyl -2-¹deoxystreptamine
ES8301107A1 (es) Un metodo para la preparacion de una formulacion farmaceutica de antibioticos de b-lactama.
IE43125L (en) Aminoglycoside derivative
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
JPS56138115A (en) Suppository containing acidic amino acid or derivative thereof
JPS57185214A (en) Suppository containing disaccharide amino sugar antibiotic substance
JPS54132219A (en) Immunoactivating agent
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide
GB1494298A (en) Taeniacidal agents
HUT48682A (en) Process for producing alpha and beta antibiotics ll-e19020 and pharmaceutical compositions comprising same
IT1246285B (it) Composizione farmaceutica per il trattamento delle infezioni polmonari

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303